We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+4.99%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$110B
AUM Growth
+$11.3B
(+11%)
Cap. Flow
+$8.89B
Cap. Flow
% of AUM
8.09%
Top 10 Holdings %
Top 10 Hldgs %
35.27%
Holding
3,643
New
809
Increased
972
Reduced
1,047
Closed
744
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.35B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$2.85B |
| 3 |
Eli Lilly
LLY
|
+$999M |
| 4 |
Coca-Cola
KO
|
+$685M |
| 5 |
Broadcom
AVGO
|
+$616M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.38B |
| 2 |
Apple
AAPL
|
+$1.12B |
| 3 |
Netflix
NFLX
|
+$678M |
| 4 |
Boston Scientific
BSX
|
+$671M |
| 5 |
Cencora
COR
|
+$627M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.19% |
| 2 | Consumer Discretionary | 12.77% |
| 3 | Healthcare | 10.45% |
| 4 | Financials | 7.74% |
| 5 | Communication Services | 5.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Stagwell
STGW
$2.27B
| $1.24M | ﹤0.01% |
253,313
-66,954
| -21% | -$348K |
|
|
IAUX
1802
i-80 Gold Corp
IAUX
$1.44B
| $1.24M | ﹤0.01% |
846,995
+495,627
| +141% | +$563K |
|
1803
Semtech
SMTC
$12.2B
| $1.24M | ﹤0.01% |
16,766
-215,240
| -93% | -$15.3M |
|
|
ANDG
1804
Andersen Group
ANDG
$5.47B
| $1.23M | ﹤0.01% |
+47,603
| New | +$1.2M |
|
1805
CVS Health
CVS
$120B
| $1.23M | ﹤0.01% |
15,444
-3,649,256
| -100% | -$288M |
|
1806
SiteOne Landscape Supply
SITE
$4.32B
| $1.22M | ﹤0.01% |
+9,800
| New | +$1.24M |
|
|
COSO
1807
CoastalSouth Bancshares
COSO
$333M
| $1.22M | ﹤0.01% |
+52,461
| New | +$1.17M |
|
1808
PUT
Expedia Group
EXPE
$38.5B
| $1.22M | ﹤0.01% |
+4,300
| New | +$1.06M |
|
1809
Entera Bio
ENTX
$148M
| $1.22M | ﹤0.01% |
627,330
| – | – |
|
1810
iShares US Pharmaceuticals ETF
IHE
$1.65B
| $1.22M | ﹤0.01% |
+14,338
| New | +$1.14M |
|
|
CLYM
1811
Climb Bio
CLYM
$795M
| $1.22M | ﹤0.01% |
304,015
+74,126
| +32% | +$178K |
|
1812
Oppenheimer Holdings
OPY
$1.21B
| $1.21M | ﹤0.01% |
16,795
-29,574
| -64% | -$2.06M |
|
1813
Agree Realty
ADC
$9.13B
| $1.21M | ﹤0.01% |
+16,836
| New | +$1.23M |
|
|
NOA
1814
North American Construction
NOA
$415M
| $1.21M | ﹤0.01% |
+84,350
| New | +$1.2M |
|
1815
HF Sinclair
DINO
$15.2B
| $1.21M | ﹤0.01% |
26,226
+2,749
| +12% | +$142K |
|
|
FINV
1816
FinVolution Group
FINV
$1.05B
| $1.2M | ﹤0.01% |
230,308
-1,234,681
| -84% | -$7.25M |
|
1817
Innovative Industrial Properties
IIPR
$1.67B
| $1.2M | ﹤0.01% |
+25,431
| New | +$1.32M |
|
1818
DMC Global
BOOM
$157M
| $1.2M | ﹤0.01% |
179,479
+17,155
| +11% | +$118K |
|
1819
Acrivon Therapeutics
ACRV
$74M
| $1.2M | ﹤0.01% |
496,081
+346,366
| +231% | +$753K |
|
|
BCIC
1820
BCP Investment Corp
BCIC
$96M
| $1.2M | ﹤0.01% |
101,038
+29,376
| +41% | +$357K |
|
|
EPRX
1821
Eupraxia Pharmaceuticals
EPRX
$438M
| $1.19M | ﹤0.01% |
+158,133
| New | +$975K |
|
|
ISBA
1822
Isabella Bank
ISBA
$312M
| $1.19M | ﹤0.01% |
+23,718
| New | +$1M |
|
1823
Children's Place
PLCE
$56.3M
| $1.19M | ﹤0.01% |
297,921
+284,861
| +2,181% | +$2.04M |
|
|
SMLR
1824
DELISTED
Semler Scientific
SMLR
| $1.18M | ﹤0.01% |
77,448
+62,076
| +404% | +$1.41M |
|
1825
Biglari Holdings Class A
BH.A
$1.2B
| $1.18M | ﹤0.01% |
677
+19
| +3% | +$31.6K |
|
Similar funds
Marshall Wace's Q4 2025 Portfolio in Review
As of Q4 2025, Marshall Wace held 3,643 positions worth $110B, up 11% from $98.6B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Marshall Wace deployed $8.89B of net new capital in Q4 2025, opening 809 new positions and adding to 972 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 4,580,704 shares worth $2.87B.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Microsoft, an estimated $1.38B trimmed.
- Marshall Wace's largest Q4 2025 buy was Vanguard S&P 500 ETF: 4,580,704 shares worth $2.87B.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $3.35B increase.
- Marshall Wace's biggest Q4 2025 reduction was Microsoft, cutting an estimated $1.38B.
- Marshall Wace fully exited Ares Management in Q4 2025, selling an estimated $146M.
- Marshall Wace's ten largest holdings make up 35% of its $110B portfolio in Q4 2025.
- Marshall Wace opened 809 new positions and closed 744 in Q4 2025.
- Marshall Wace's portfolio value rose 11% quarter-over-quarter to $110B.
Based on Marshall Wace's 13F filing for Q4 2025, filed 13 Feb 2026.